Glucotrack (GCTK) Research & Development (2016 - 2020)
Historic Research & Development for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to $264000.0.
- Glucotrack's Research & Development fell 3439.1% to $264000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year decrease of 460.77%. This contributed to the annual value of $4.7 million for FY2023, which is N/A changed from last year.
- Glucotrack's Research & Development amounted to $264000.0 in Q4 2020, which was down 3439.1% from $476000.0 recorded in Q3 2020.
- Glucotrack's Research & Development's 5-year high stood at $1.4 million during Q4 2017, with a 5-year trough of $264000.0 in Q4 2020.
- Its 5-year average for Research & Development is $609477.6, with a median of $580517.0 in 2016.
- In the last 5 years, Glucotrack's Research & Development skyrocketed by 10971.89% in 2017 and then plummeted by 6687.53% in 2019.
- Quarter analysis of 5 years shows Glucotrack's Research & Development stood at $654984.0 in 2016, then skyrocketed by 109.72% to $1.4 million in 2017, then fell by 11.57% to $1.2 million in 2018, then tumbled by 66.88% to $402384.0 in 2019, then tumbled by 34.39% to $264000.0 in 2020.
- Its last three reported values are $264000.0 in Q4 2020, $476000.0 for Q3 2020, and $379000.0 during Q2 2020.